Dedicated regulatory support packages for TheraPEAK® GMP Solutions

Cell & Gene Therapy Insights 2021; 7(3), 679

10.18609/cgti.2021.096

Published: 22 June 2021
FastFacts
Hippolitus Odukwu


Watch the video or read the poster to learn: 

  • The regulatory challenges facing cell and gene therapy manufacturers 
  • Accelerating time to market with GMP solutions and regulatory support packages 
  • Available TheraPEAK® Regulatory Support Packages  

About the author

Hippolitus Odukwu is the Head of Regulatory Affairs for Lonza Bioscience Solutions with over 25 years of industry experience in regulatory and quality operations. He joined Lonza in 2017. Prior to joining Lonza, Hippolitus spent 18 years in various roles at Angelini, Biovail and Mediatech supporting clinical and non-clinical developments, and global marketing authorizations application for medical devices/IVD, drugs, biologics and bioprocessing reagents. Hippolitus holds a Masters degree in Chemistry from George Mason University and MBA from University of Maryland University College.